Back

Plasminogen activator inhibitor -1 and circulating ceruloplasmin levels in men with heart failure with preserved ejection fraction with concomitant prostate cancer

21 May 2023 (11:40 - 12:33)
Organised by: Logo
Congress Presentation Part of: ePosters in cardiovascular disease in special populations 1 Cardio-Oncology HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Oksana Sirenko

Dnipro state medical university, Dnipro (Ukraine)

6 More presentations in this session

Presentation thumbnail
A new maternal heart clinic - early experiences and challenges in a quaternary hospital in Western Australia.
Doctor R. Chetty (Perth, AU)
Abstract Slides
Presentation thumbnail
Safety and utility of cardiopulmonary exercise testing in non-Hodgkin lymphoma patients undergoing chemotherapy
Doctor D. Bursacovschi (Chisinau, MD)
Abstract Slides
Presentation thumbnail
The prognostic value of sodium-glucose co-transporter-2 inhibitors therapy among patients with cancer and diabetes mellitus, treated with immune checkpoint inhibitors
Doctor M. Laufer-Perl (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Relationship between clinical and echocardiographic outcomes and cardioprotective drugs in a population of female breast cancer patients exposed to anthracyclines
Doctor C. Oliveira (Porto, PT)
Abstract Slides
Presentation thumbnail
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients
Doctor A. Cuomo (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in cardiovascular disease in special populations 1

The Event

Event poster

Heart Failure 2023

21 May 2023 11:40 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources